αV ß6 Integrin: An Intriguing Target for COVID-19 and Related Diseases.
Chembiochem
; 22(15): 2516-2520, 2021 08 03.
Article
in English
| MEDLINE | ID: covidwho-1400765
ABSTRACT
The outbreak of SARS-CoV-2 has been an extraordinary event that constituted a global health emergency. As the novel coronavirus is continuing to spread over the world, the need for therapeutic agents to control this pandemic is increasing. αV ß6 Integrin may be an intriguing target not only for the inhibition of SARS-CoV-2 entry, but also for the diagnosis/treatment of COVID-19 related fibrosis, an emerging type of fibrotic disease which will probably affect a significant part of the recovered patients. In this short article, the possible role of this integrin for fighting COVID-19 is discussed on the basis of recently published evidence, showing how its underestimated involvement may be interesting for the development of novel pharmacological tools.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Fibrosis
/
Integrin beta Chains
/
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Chembiochem
Journal subject:
Biochemistry
Year:
2021
Document Type:
Article
Affiliation country:
Cbic.202100209
Similar
MEDLINE
...
LILACS
LIS